TY - JOUR
T1 - Antimicrobial consumption and antimicrobial resistance: A snapshot of an Italian neuromuscular rehabilitation center
AU - Cascio, Antonio
AU - Barberi, Giuseppina
AU - Dell'Utri, Pia
AU - De Cola, Maria Cristina
AU - Alagna, Bernardo
AU - Melardi, Sara
AU - Bramanti, Placido
AU - Bramanti, Placido
PY - 2017
Y1 - 2017
N2 - The paper presents a snapshot of the incidence of antimicrobial-resistant microorganisms and antimicrobial consumption in an Italian rehabilitation center over a two-year period (2014-2015). Data on microorganism identification and antimicrobial susceptibility testing were obtained from the diagnostic laboratory of the hospital. A set of indicators was assessed, including the incidence density of resistant isolates per 1000 patient-days (IDRI). Data on antimicrobial consumption, semi-Annually, obtained from the hospital pharmacy, were expressed as Defined Daily Dose (DDD) per 1000 patient-days. The most frequently isolated microorganism was Klebsiella pneumoniae (19.3%), and a significant increase in piperacillin/tazobactam-resistant K. pneumoniae (p=0.04) was observed. Among all antimicrobials used, carbapenems were the most prescribed antibiotic class (31%).
AB - The paper presents a snapshot of the incidence of antimicrobial-resistant microorganisms and antimicrobial consumption in an Italian rehabilitation center over a two-year period (2014-2015). Data on microorganism identification and antimicrobial susceptibility testing were obtained from the diagnostic laboratory of the hospital. A set of indicators was assessed, including the incidence density of resistant isolates per 1000 patient-days (IDRI). Data on antimicrobial consumption, semi-Annually, obtained from the hospital pharmacy, were expressed as Defined Daily Dose (DDD) per 1000 patient-days. The most frequently isolated microorganism was Klebsiella pneumoniae (19.3%), and a significant increase in piperacillin/tazobactam-resistant K. pneumoniae (p=0.04) was observed. Among all antimicrobials used, carbapenems were the most prescribed antibiotic class (31%).
UR - http://hdl.handle.net/10447/290589
UR - http://www.newmicrobiologica.org/PUB/allegati_pdf/2017/2/119.pdf
M3 - Article
VL - 40
SP - 119
EP - 129
JO - New Microbiologica
JF - New Microbiologica
SN - 1121-7138
ER -